356 related articles for article (PubMed ID: 18407432)
21. Intensity-modulated radiotherapy for pituitary adenomas: the preliminary report of the Cleveland Clinic experience.
Mackley HB; Reddy CA; Lee SY; Harnisch GA; Mayberg MR; Hamrahian AH; Suh JH
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):232-9. PubMed ID: 17084541
[TBL] [Abstract][Full Text] [Related]
22. Postoperative intensity-modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: technique, early outcomes, and toxicity.
Hoppe BS; Wolden SL; Zelefsky MJ; Mechalakos JG; Shah JP; Kraus DH; Lee N
Head Neck; 2008 Jul; 30(7):925-32. PubMed ID: 18302261
[TBL] [Abstract][Full Text] [Related]
23. A treatment planning study on glioblastoma with different techniques using boron neutron capture therapy, 3-dimensional conformal radiotherapy, and intensity modulated radiotherapy.
Jung SH; Yoon SM; Park SH; Choi IS; Kim JK; Choi EK; Ahn SD; Lee SW; Song SY; Kim JH
Appl Radiat Isot; 2009; 67(7-8):1180-4. PubMed ID: 19321353
[TBL] [Abstract][Full Text] [Related]
24. Does intensity-modulated stereotactic radiotherapy achieve superior target conformity than conventional stereotactic radiotherapy in different intracranial tumours?
Sharma SD; Jalali R; Phurailatpam RD; Gupta T
Clin Oncol (R Coll Radiol); 2009 Jun; 21(5):408-16. PubMed ID: 19268555
[TBL] [Abstract][Full Text] [Related]
25. Impact of intensity-modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity.
Alektiar KM; Brennan MF; Healey JH; Singer S
J Clin Oncol; 2008 Jul; 26(20):3440-4. PubMed ID: 18612160
[TBL] [Abstract][Full Text] [Related]
26. GliaSite brachytherapy boost as part of initial treatment of glioblastoma multiforme: a retrospective multi-institutional pilot study.
Welsh J; Sanan A; Gabayan AJ; Green SB; Lustig R; Burri S; Kwong E; Stea B
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):159-65. PubMed ID: 17331666
[TBL] [Abstract][Full Text] [Related]
27. Multifocal glioblastoma multiforme: prognostic factors and patterns of progression.
Showalter TN; Andrel J; Andrews DW; Curran WJ; Daskalakis C; Werner-Wasik M
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):820-4. PubMed ID: 17499453
[TBL] [Abstract][Full Text] [Related]
28. Effects of concurrent topotecan and radiation on 6-month progression-free survival in the primary treatment of glioblastoma multiforme.
Grabenbauer GG; Gerber KD; Ganslandt O; Richter A; Klautke G; Birkmann J; Meyer M
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):164-9. PubMed ID: 19695435
[TBL] [Abstract][Full Text] [Related]
29. Preservation of quality of life by preradiotherapy stereotactic radiosurgery for unresectable glioblastoma multiforme.
Kong DS; Nam DH; Lee JI; Park K; Kim JH
J Neurosurg; 2006 Dec; 105 Suppl():139-43. PubMed ID: 18503347
[TBL] [Abstract][Full Text] [Related]
30. Temporal lobe reactions after carbon ion radiation therapy: comparison of relative biological effectiveness-weighted tolerance doses predicted by local effect models I and IV.
Gillmann C; Jäkel O; Schlampp I; Karger CP
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1136-41. PubMed ID: 24661667
[TBL] [Abstract][Full Text] [Related]
31. Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer.
Fonteyne V; De Gersem W; De Neve W; Jacobs F; Lumen N; Vandecasteele K; Villeirs G; De Meerleer G
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1013-20. PubMed ID: 19386427
[TBL] [Abstract][Full Text] [Related]
32. [Magnetic resonance perfusion weighted imaging manifestation of late radiation-induced encephalopathy at temporal lobe].
Zhao JQ; Liang BL; Shen J; Zhang XH; Sun Y
Ai Zheng; 2005 Sep; 24(9):1102-5. PubMed ID: 16159433
[TBL] [Abstract][Full Text] [Related]
33. Radiotherapy planning for glioblastoma based on a tumor growth model: improving target volume delineation.
Unkelbach J; Menze BH; Konukoglu E; Dittmann F; Le M; Ayache N; Shih HA
Phys Med Biol; 2014 Feb; 59(3):747-70. PubMed ID: 24440875
[TBL] [Abstract][Full Text] [Related]
34. Gamma Knife surgery for low-grade astrocytomas: evaluation of long-term outcome based on a 10-year experience.
Wang LW; Shiau CY; Chung WY; Wu HM; Guo WY; Liu KD; Ho DM; Wong TT; Pan DH
J Neurosurg; 2006 Dec; 105 Suppl():127-32. PubMed ID: 18503345
[TBL] [Abstract][Full Text] [Related]
35. Infratemporal and intraorbital metastasis of the glioblastoma multiforme. A case report.
Erdem A; Tun K; Ugur HC; Erekul S
Neurochirurgie; 2004 Jun; 50(2-3 Pt 1):101-4. PubMed ID: 15213638
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of variability in target volume delineation for newly diagnosed glioblastoma: a multi-institutional study from the Korean Radiation Oncology Group.
Wee CW; Sung W; Kang HC; Cho KH; Han TJ; Jeong BK; Jeong JU; Kim H; Kim IA; Kim JH; Kim SH; Kim S; Lee DS; Lee MY; Lim DH; Park HL; Suh CO; Yoon SM; Kim IH
Radiat Oncol; 2015 Jul; 10():137. PubMed ID: 26134973
[TBL] [Abstract][Full Text] [Related]
37. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.
Dimopoulos JC; Lang S; Kirisits C; Fidarova EF; Berger D; Georg P; Dörr W; Pötter R
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):56-63. PubMed ID: 19289267
[TBL] [Abstract][Full Text] [Related]
38. Intensity-modulated radiation therapy in childhood ependymoma.
Schroeder TM; Chintagumpala M; Okcu MF; Chiu JK; Teh BS; Woo SY; Paulino AC
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):987-93. PubMed ID: 18258381
[TBL] [Abstract][Full Text] [Related]
39. Image-guided intensity-modulated photon radiotherapy using multifractionated regimen to paraspinal chordomas and rare sarcomas.
Terezakis SA; Lovelock DM; Bilsky MH; Hunt MA; Zatcky J; Yamada Y
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1502-8. PubMed ID: 17689028
[TBL] [Abstract][Full Text] [Related]
40. Neuropathological postmortem evaluation of BNCT for GBM.
H-Stenstam B; Pellettieri L; Sköld K; Rezaei A; Brun A
Acta Neurol Scand; 2007 Sep; 116(3):169-76. PubMed ID: 17714330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
